Clinical Trial Update: Rate of Prolonged Response After Stopping Thrombopoietin-receptor Agonists Treatment in ITP [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating how often patients experience a prolonged response after stopping thrombopoietin-receptor agonists in persistent immune thrombocytopeni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Persistent or Chronic ITP | Phase 4 | Status: COMPLETED